2016 Fiscal Year Final Research Report
Roles of MafK-Gpnmb axis in malignant progression of cancer and molecular targeted therapy
Project/Area Number |
15K19070
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Experimental pathology
|
Research Institution | University of Tsukuba |
Principal Investigator |
OKITA Yukari 筑波大学, 医学医療系, 研究員 (30743710)
|
Research Collaborator |
KATO Mitsuyasu 筑波大学, 医学医療系, 教授 (20194855)
|
Project Period (FY) |
2015-04-01 – 2017-03-31
|
Keywords | MafK / GPNMB / 腫瘍形成 / EMT / 転移形成 / 分子標的治療 |
Outline of Final Research Achievements |
Previously we showed that the transcription factor MafK is involved in induction of epithelial-mesenchymal transition (EMT) and malignant progression of breast cancer cells. Furthermore, we identified glycoprotein nmb (GPNMB) as a target of MafK, which also has the functions as an inducer of EMT and tumorigenesis. In this project, we further investigated the molecular mechanisms how MafK-GPNMB axis contributes to EMT induction and tumorigenesis. Then, we found post-translational modification of MafK is important for functional regulation of MafK in EMT induction and tumorigenesis. Moreover, we identified some domains or motifs which are essential for GPNMB-mediated EMT induction and tumorigenesis. We are going to investigate further detail mechanisms in order to find new target for breast cancer treatment.
|
Free Research Field |
腫瘍学
|